Oppenheimer & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.5M | Sell |
34,862
-3,592
| -9% | -$277K | 0.03% | 518 |
|
|
2025
Q4 | $3.05M | Buy |
38,454
+2,811
| +8% | +$222K | 0.04% | 428 |
|
|
2025
Q3 | $2.69M | Sell |
35,643
-17,055
| -32% | -$1.17M | 0.03% | 518 |
|
|
2025
Q2 | $3.64M | Buy |
52,698
+12,358
| +31% | +$810K | 0.05% | 401 |
|
|
2025
Q1 | $2.73M | Sell |
40,340
-63,038
| -61% | -$3.77M | 0.04% | 465 |
|
|
2024
Q4 | $4.64M | Buy |
103,378
+3,530
| +4% | +$198K | 0.07% | 305 |
|
|
2024
Q3 | $6.28M | Buy |
99,848
+5,325
| +6% | +$311K | 0.1% | 234 |
|
|
2024
Q2 | $5.58M | Sell |
94,523
-40,502
| -30% | -$2.53M | 0.09% | 252 |
|
|
2024
Q1 | $10.8M | Buy |
135,025
+6,137
| +5% | +$469K | 0.18% | 127 |
|
|
2023
Q4 | $10.2M | Sell |
128,888
-12,324
| -9% | -$877K | 0.19% | 119 |
|
|
2023
Q3 | $9.86M | Sell |
141,212
-43,047
| -23% | -$3.05M | 0.2% | 105 |
|
|
2023
Q2 | $12.7M | Buy |
184,259
+14,661
| +9% | +$1.04M | 0.25% | 78 |
|
|
2023
Q1 | $12.6M | Buy |
169,598
+458
| +0.3% | +$38.4K | 0.27% | 78 |
|
|
2022
Q4 | $15.8M | Sell |
169,140
-7,302
| -4% | -$705K | 0.36% | 55 |
|
|
2022
Q3 | $16.8M | Buy |
176,442
+6,058
| +4% | +$600K | 0.39% | 47 |
|
|
2022
Q2 | $15.8M | Sell |
170,384
-18,038
| -10% | -$1.76M | 0.34% | 57 |
|
|
2022
Q1 | $19.1M | Sell |
188,422
-27,264
| -13% | -$2.86M | 0.34% | 57 |
|
|
2021
Q4 | $22.3M | Buy |
215,686
+7,745
| +4% | +$716K | 0.39% | 45 |
|
|
2021
Q3 | $17.6M | Buy |
207,941
+482
| +0.2% | +$40.4K | 0.33% | 56 |
|
|
2021
Q2 | $17.3M | Sell |
207,459
-18,598
| -8% | -$1.52M | 0.31% | 62 |
|
|
2021
Q1 | $17M | Buy |
226,057
+7,906
| +4% | +$576K | 0.34% | 55 |
|
|
2020
Q4 | $14.9M | Buy |
218,151
+27,958
| +15% | +$1.82M | 0.31% | 67 |
|
|
2020
Q3 | $11.1M | Sell |
190,193
-15,740
| -8% | -$979K | 0.28% | 70 |
|
|
2020
Q2 | $13.4M | Buy |
205,933
+1,604
| +0.8% | +$101K | 0.35% | 59 |
|
|
2020
Q1 | $12.1M | Buy |
204,329
+5,680
| +3% | +$379K | 0.37% | 58 |
|
|
2019
Q4 | $14.8M | Buy |
198,649
+2,326
| +1% | +$163K | 0.37% | 59 |
|
|
2019
Q3 | $12.4M | Buy |
196,323
+1,128
| +0.6% | +$66.8K | 0.34% | 66 |
|
|
2019
Q2 | $10.6M | Buy |
195,195
+16,570
| +9% | +$892K | 0.29% | 74 |
|
|
2019
Q1 | $9.63M | Buy |
178,625
+56,830
| +47% | +$3.51M | 0.26% | 83 |
|
|
2018
Q4 | $7.98M | Buy |
121,795
+21,780
| +22% | +$1.63M | 0.25% | 90 |
|
|
2018
Q3 | $7.87M | Buy |
100,015
+19,181
| +24% | +$1.37M | 0.2% | 101 |
|
|
2018
Q2 | $5.2M | Buy |
80,834
+7,675
| +10% | +$506K | 0.14% | 163 |
|
|
2018
Q1 | $4.55M | Buy |
73,159
+7,388
| +11% | +$530K | 0.12% | 193 |
|
|
2017
Q4 | $4.77M | Buy |
65,771
+7,111
| +12% | +$517K | 0.12% | 199 |
|
|
2017
Q3 | $4.77M | Buy |
58,660
+2,050
| +4% | +$162K | 0.13% | 187 |
|
|
2017
Q2 | $4.55M | Sell |
56,610
-5,885
| -9% | -$465K | 0.13% | 196 |
|
|
2017
Q1 | $4.91M | Buy |
62,495
+10,450
| +20% | +$834K | 0.14% | 168 |
|
|
2016
Q4 | $4.11M | Sell |
52,045
-74,137
| -59% | -$6M | 0.12% | 199 |
|
|
2016
Q3 | $11.2M | Sell |
126,182
-1,304
| -1% | -$123K | 0.33% | 69 |
|
|
2016
Q2 | $12.2M | Buy |
127,486
+3,921
| +3% | +$391K | 0.36% | 69 |
|
|
2016
Q1 | $12.8M | Buy |
123,565
+52,141
| +73% | +$5.07M | 0.39% | 63 |
|
|
2015
Q4 | $6.98M | Buy |
71,424
+6,215
| +10% | +$609K | 0.21% | 108 |
|
|
2015
Q3 | $6.29M | Sell |
65,209
-577
| -0.9% | -$60.7K | 0.19% | 122 |
|
|
2015
Q2 | $6.9M | Buy |
65,786
+14,546
| +28% | +$1.49M | 0.19% | 120 |
|
|
2015
Q1 | $5.29M | Buy |
51,240
+12,126
| +31% | +$1.23M | 0.14% | 162 |
|
|
2014
Q4 | $3.77M | Buy |
39,114
+10,490
| +37% | +$924K | 0.11% | 226 |
|
|
2014
Q3 | $2.28M | Sell |
28,624
-2,057
| -7% | -$162K | 0.07% | 337 |
|
|
2014
Q2 | $2.31M | Buy |
30,681
+365
| +1% | +$27.6K | 0.07% | 335 |
|
|
2014
Q1 | $2.27M | Buy |
30,316
+3,894
| +15% | +$275K | 0.07% | 348 |
|
|
2013
Q4 | $1.89M | Sell |
26,422
-495
| -2% | -$31.8K | 0.06% | 368 |
|
|
2013
Q3 | $1.53M | Sell |
26,917
-951
| -3% | -$56.7K | 0.05% | 399 |
|
|
2013
Q2 | $1.59M | Buy |
+27,868
| New | +$1.61M | 0.06% | 364 |
|
Other funds holding CVS
VCM
VPM
Oppenheimer & Co's CVS Position: Q1 2026 in Review
Oppenheimer & Co reduced its CVS Health (CVS) stake by 9.3% in Q1 2026, selling an estimated $277K and leaving 34,862 shares worth $2.5M. The position accounts for 0.03% of the portfolio, ranked #518.
Oppenheimer & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.3M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Oppenheimer & Co held 34,862 shares of CVS Health worth $2.5M as of Q1 2026.
- Oppenheimer & Co sold 3,592 CVS Health shares in Q1 2026, an estimated $277K.
- CVS Health made up 0.03% of Oppenheimer & Co's portfolio in Q1 2026, its #518 holding.
- Oppenheimer & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's CVS Health position peaked at $22.3M in Q4 2021.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.